1. Regulation (EC) No 726/2004 of the European Parliament and of the Council of 31 March 2004 laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency. [cited 2019 Nov 15]. Available from: https://ec.europa.eu/health/sites/health/files/files/eudralex/vol-1/reg_2004_726/reg_2004_726_en.pdf
2. European Medicines Agency: Medicines for use outside of the EU. [cited 2020 Jan 19]. Available from: https://www.ema.europa.eu/en/human-regulatory/marketing-authorisation/medicines-use-outside-european-union
3. European Medicines Agency: evaluation by CHMP. [cited 2020 Jan 19]. Available from: https://www.ema.europa.eu/en/about-us/what-we-do#evaluate-applications-for-marketing-authorisation-section
4. World Health Organization. Prequalification and collaborative registration. [cited 2020 Jan 19]. Available from: https://www.who.int/immunization_standards/vaccine_quality/WHO_TRS_996_annex08.pdf
5. Defining the strategic vision for the EMA ‘Article 58ʹ process. 2015 Sep. [cited 2019 Nov 15]. Available from: https://www.ema.europa.eu/en/documents/other/defining-strategic-vision-ema-article-58-process-final-read-out_en.pdf